Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others in patients with GIST.

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

Blueprint Medicines Corporation BPMC reported fourth-quarter 2024 adjusted loss of 79 cents per share, wider than the Zacks ...

总体而言，这篇论文的研究成果为胃黏膜下肿瘤的内镜治疗提供了重要参考。半钝性剥离法展现出的优势为临床医生在选择治疗方案时提供了新的有力选项，有望在未来的临床实践中得到更广泛的应用，进一步改善患者的治疗体验和预后。但同时，研究的局限性也为后续研究指明了方向，激励更多科研人员深入探索，不断完善胃黏膜下肿瘤的内镜治疗技术 。

Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 7,710,000 shares, a growth of ...

FDCS 是一种起源于生发中心滤泡树突状细胞（Follicular dendritic cells，FDCs）的罕见恶性肿瘤，常出现淋巴或结外播散。世界卫生组织（WHO）将其归类为罕见肿瘤，其肿瘤细胞呈梭形或椭圆形，具有树突状细胞的形态和免疫表型特征。1986 年，Monda L 等人首次描述了 FDCS，最初它主要与淋巴结相关，曾被称为网状细胞肉瘤或树突状网状细胞肉瘤。1994 年，Chan ...

Kingsview Wealth Management LLC lowered its holdings in Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 5.9% in the fourth quarter, according to its most recent 13F filing with the Securities & ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...